Release Date: 16/04/19 16:49 Summary: A LETTER TO WMK SHAREHOLDERS FROM WATERMARK FUNDS MANAGEMENT Price Sensitive: No Download Document 580.44KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status